Navigation Links
Savara Pharmaceuticals Announces Formation of Clinical Advisory Board
Date:2/26/2013

ts. Vancomycin administered by IV is the antibiotic of choice for the treatment of MRSA-related bronchopneumonia, however, IV administration, poor penetration into the lungs and systemic toxicities limits its use in a chronic setting. By delivering vancomycin directly to the site of infection, AeroVanc is expected to improve clinical efficacy and reduce adverse effects due to systemic drug exposure.

AeroVanc has demonstrated positive safety and tolerability in Phase I clinical studies conducted in healthy subjects and CF patients, with a pharmacokinetic profile that supports its potential as a twice-daily treatment for pulmonary MRSA infection.

About Cystic Fibrosis and MRSA 
Cystic fibrosis is a life-shortening genetic disease characterized by thick, sticky mucus in the lungs and frequent lung infections, which result in loss of lung function. As the disease progresses, the lungs of CF patients are typically infected with bacteria that are difficult to eradicate. Such infections are usually treated with inhaled antibiotics. In recent years, infection by MRSA has become increasingly common, with a prevalence of almost 30 percent of the estimated 30,000 CF patients in the United States. Persistent MRSA lung infection is associated with faster decline in lung function and a significantly shortened life expectancy. Currently there is no approved inhaled therapy for MRSA lung infection for CF patients.

About Savara Pharmaceuticals 
Savara Pharmaceuticals is an emerging specialty pharmaceutical company developing innovative pulmonary drugs for the treatment of serious and life-threatening conditions. The company's lead product, AeroVanc™ (vancomycin hydrochloride inhalation powder), is the first dry powder inhaled antibiotic for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection in patients with cystic fibrosis. For more information, please see Savara's website a
'/>"/>

SOURCE Savara Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Savara Pharmaceuticals AeroVanc Granted U.S. Orphan Drug Designation for the Treatment of MRSA Lung Infection in Cystic Fibrosis Patients
2. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
3. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
4. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
5. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Monday, March 4
6. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
7. Reckitt Benckiser Pharmaceuticals Inc. Receives FDA Response to Citizens Petition
8. Keryx Biopharmaceuticals to Present at the Citigroup 2013 Global Healthcare Conference
9. Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2012
10. Tomorrows Outlook in Todays Market - Research Report on Toyota Motor Corporation, Honda Motor Co., Ltd., Yahoo! Inc., AOL, Inc. and Aegerion Pharmaceuticals, Inc.
11. Webcast Alert: Isis Pharmaceuticals 2012 Financial Results and Highlights Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014 On ... ("Plaintiff") filed suit in the 116 th ... Texas , against RegenLab USA, LLC ... and Prospective Business Relationships through false and ... and, Business Disparagement through libel, disparagement, ...
(Date:7/23/2014)... 2014 Research and Markets   ... Electrophysiology Ablation Catheters Market 2014-2018" report to ... Catheter ablation is a minimally ... electrical pathways from sections of the heart that ... arrhythmias). Cardiac arrhythmias can be of several types, ...
(Date:7/23/2014)... Top Staten Island Pediatrician Dr. Michael Gabriel ... discusses tips for parents about pool safety for children. ... to US News article, "Drowning is the leading ... 1 to 4, and can occur in as little as ... article says that watching a child in the water every ...
Breaking Medicine Technology:Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 3Premier Staten Island Pediatrician Dr. Michael Gabriel Comments On Article Discussing Pool Safety Tips for Parents 2
... Ill., April 1, 2011 Hospira ... of clinical information and medication delivery technologies, today announced ... system , used by hospitals to help improve patient ... (HAIs). The enhanced TheraDoc system includes new features and ...
... & Dempsey is launching Accountable Care Forum - ... analysis of the emerging accountable care organization (ACO) landscape. ... Centers for Medicare & Medicaid Services (CMS). ... reform legislation affecting physicians and hospitals across the United ...
Cached Medicine Technology:Hospira Launches Enhanced TheraDoc™ Clinical Surveillance System to Support Patient Safety and Help Improve Care 2Hospira Launches Enhanced TheraDoc™ Clinical Surveillance System to Support Patient Safety and Help Improve Care 3Online Forum for Accountable Care Organization Developments Launches Today; Squire Sanders Sponsorship Reflects Commitment to Leadership in Emerging Health Policy Debate 2
(Date:7/23/2014)... July 23, 2014 Obtaining insurance information ... the average consumer. The Quotes Pros company is launching ... 50 states this year to make research faster at ... issuing the rates information are actual agencies that specialize ... inside the U.S. An advantage to adults who use ...
(Date:7/23/2014)... and young adults living near Sellafield or Dounreay since ... developing cancer according to research published in the ... from the Childhood Cancer Research Group at the University ... between 1963 and 2006 among those who were under ... No difference was found in cancer incidence from 1991-2006 ...
(Date:7/23/2014)... FL (PRWEB) July 23, 2014 In ... place Aug. 10-16, Millennium Treatment Group is providing tips ... has existed in society ever since man first figured ... Substance abuse treatment has existed since shortly thereafter. Its ... a problem and then developing a way to combat ...
(Date:7/23/2014)... Randy Dotinga HealthDay Reporter ... powerful drug combo may not be as effective against ... human cells suggests that one of the medications might ... study,s findings aren,t definitive, and there,s still hope for ... lumacaftor, according to the study,s senior author. "The ...
(Date:7/23/2014)... NJ (PRWEB) July 23, 2014 Celebrating ... for New Jersey today announced the awarding of $1,070,000 ... a special award in recognition of the Foundation’s 1,000th ... proud to continue our tradition of supporting community-based organizations ... the quality of life in the Garden State,” said ...
Breaking Medicine News(10 mins):Health News:Term Life Insurance Prices for All 50 States Now Explored at Insurer Website 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 3Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 3Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 3Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 4Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 5
... to tackle issue , , THURSDAY, March 26 (HealthDay ... to be tainted with traces of medications and common ... Environmental Protection Agency and Baylor University. , The common ... antidepressants were among the seven types of pharmaceuticals found ...
... Criteria include added section on hospital care and advice ... 26 (HealthDay News) -- New guidelines for treatment of ... Association and the American College of Cardiology, with a ... condition and also on the treatment of blacks. , ...
... - A one-of-a-kind graduate program that focuses on the ... at The University of Texas M. D. Anderson Cancer ... The University of Texas System. , The Graduate Program ... on understanding and attacking the spread of cancer from ...
... This release is available in French . ... Africa increases, so does the need for improved review of ... work on increasing the quality of research, we should also ... established National Bioethics Committee of Gabon, which was established with ...
... Contender, Nate "The Great" Marquardt, Joins the Growing List of ... , ... Denver, CO (PRWEB) March ... title contender, Nate "The Great" Marquardt, recently underwent successful PRK ...
... annually, according to Millennium Research GroupWALTHAM, Mass., March ... US Markets for Large-Joint Reconstructive Implants 2009 ... segment of the large-joint reconstructive implant market through ... of over 25%. Hip resurfacing is championed ...
Cached Medicine News:Health News:Fish in U.S. Rivers Tainted With Common Medications 2Health News:New Guidelines for Treating Heart Failure 2Health News:New Guidelines for Treating Heart Failure 3Health News:M. D. Anderson launches graduate program in cancer metastasis 2Health News:Gabon establishes national ethics committee 2Health News:Ultimate Fighting Championship Title Contender Joins the List of Professional Athletes Choosing Denver's Icon LASIK for Laser Vision Correction 2Health News:Ultimate Fighting Championship Title Contender Joins the List of Professional Athletes Choosing Denver's Icon LASIK for Laser Vision Correction 3Health News:Hip Resurfacing Championed as a Bone-Preserving Alternative to Total Hip Replacement 2Health News:Hip Resurfacing Championed as a Bone-Preserving Alternative to Total Hip Replacement 3
... Variable cutting speeds (guillotine movements) are ... when switched off, thus minimizing tissue trauma. ... action, or both can be combined together. ... uni or bi-manual techniques. Lightweight autoclavable hand-pieces ...
...
...
LASIK Retreatment Forceps - Also available in Titanium...
Medicine Products: